Arturo Araya – VJRegenMed

OCELLOS: A novel advanced therapy orchestration platform

Simon Ng — Wed, 02 Mar 2022 11:58:16 +0000

Arturo Araya, MBA, TrakCel, Cardiff, UK, provides an overview of TrakCel’s OCELLOS platform and its role in the digitization of supply chain management. The cloud-based platform provides a scalable service that can be adaptable to different countries and their regulations and unlike a code-based system, OCELLOS provides the flexibility to respond to changes within the future via the partner MuleSoft platform. The modular nature of the platform additionally enables the system to be repaired more efficiently, as the whole platform does not need to be taken down for maintenance. He also highlights the potential integration of future technologies in OCELLOS, such as blockchain which may be utilized by healthcare systems. This interview took place at Advanced Therapies Week 2022.

How cell orchestration systems can assist advanced therapy developers

Simon Ng — Wed, 02 Mar 2022 11:58:15 +0000

Arturo Araya, MBA, TrakCel, Cardiff, UK, discusses the benefits of using cloud-based cell orchestration systems. For smaller companies, the use of such systems enables healthcare professionals and other relevant staff to efficiently carry out administrative tasks relating to patients in clinical trials, lowering the cost of conducing research. In the case of larger pharmaceuticals which may have multiple legacy systems in place, the use of cell orchestration systems enables all the legacy systems to be connected. This interview took place at Advanced Therapies Week 2022.

Addressing supply chain issues in clinical trials

Simon Ng — Tue, 15 Feb 2022 12:24:06 +0000

Arturo Araya, MBA, TrakCel, Cardiff, UK, describes challenges in supply chain management in the cell and gene therapy (CGT) sector. Due to the complexity of advanced therapies, there are multiple service providers contributing to each component of the product, resulting in a higher margin of error. A high cost of failure can also result in severe consequences if the therapy is administered to the wrong patient and manufacturing and supply chain capabilities can additionally be put under strain due to the sheer number of clinical trials occurring. This interview took place at Advanced Therapies Week 2022.

Digitization in the CGT sector

Simon Ng — Tue, 15 Feb 2022 12:24:05 +0000

Arturo Araya, MBA, TrakCel, Cardiff, UK, discusses the increasing significance of digitization in the advanced therapies industry. The advent of a centralized tracking system has resulted in data from different suppliers relating to the product to be efficiently audited, especially by regulators to assess safety. Whilst digitization has enabled specialized organizations to fulfil particular tasks, the data needs to be properly tracked to be processed and privacy policies may restrict access to patients from a certain region. This interview took place at Advanced Therapies Week 2022.